报价延迟最少15分钟:2026/03/10 03:21 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
162.79 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
7.15/10.03
|
|
企业价值
335.13B
|
| 资产负债 |
|
每股账面净值
24.18
|
| 现金流量 |
|
现金流量率
0.06
|
| 损益表 |
|
收益
56.67B
|
|
每股收益
28.41
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includesoff-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue. |
